Announcement Company Merrill Lynch International TIDMTTP Headline EMM Disclosure Released 12:24 21 Feb 2003 Number 8083H FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EMM Merrill Lynch International Date of disclosure 21 February 2003 Date of dealing 20 February 2003 Telephone number 020 7996 1038 Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies: 20 February 2003 Cambridge Antibody Tech Group - Common Celltech Group Plc - Ordinary Oxford Glycosciences Plc - Common AMENDMENT state which element(s) of disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price. For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel. No: 0171 638 0129 FORM 38.5 Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in Oxford Glycosciences Plc Class of security Common Date of disclosure 21 February 2003 Date of dealing 20 February 2003 Name of EMM Merrill Lynch International Name of offeree/offeror with whom connected Cambridge Antibody Tech Group Number of securities purchased 50,330 Highest price paid* GBP1.90 Lowest price paid* GBP1.88 Number of securities sold 50,000 Highest price paid* GBP1.91 Lowest price paid* GBP1.91 *Currency must be stated FORM 38.5 Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in Celltech Group Plc Class of security Ordinary Date of disclosure 21 February 2003 Date of dealing 20 February 2003 Name of EMM Merrill Lynch International Name of offeree/offeror with whom connected Cambridge Antibody Technology Group Plc Number of securities purchased 109,509 Highest price paid* GBP3.51 Lowest price paid* GBP3.38 Number of securities sold 161,270 Highest price paid* GBP3.50 Lowest price paid* GBP3.37 *Currency must be stated FORM 38.5 Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT MARKET-MAKERS: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Dealing in Cambridge Antibody Tech Group Class of security Common Date of disclosure 21 February 2003 Date of dealing 20 February 2003 Name of EMM Merrill Lynch International Name of offeree/offeror with whom connected Cambridge Antibody Tech Group Number of securities purchased 500,000 Highest price paid* GBP4.40 Lowest price paid* GBP4.37 Number of securities sold 483,200 Highest price paid* GBP4.40 Lowest price paid* GBP4.37 *Currency must be stated END